4/A//SEC Filing
BESHAR LUKE M 4/A
Accession 0001209191-20-035842
CIK 0001359931other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 1:30 PM ET
Size
10.0 KB
Accession
0001209191-20-035842
Insider Transaction Report
Form 4/AAmended
BESHAR LUKE M
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-01-09+6,676→ 6,676 totalExercise: $9.18Exp: 2028-12-03→ Common Stock (6,676 underlying) - Award
Stock Option (Right to Buy)
2020-01-09+12,399→ 12,399 totalExercise: $9.18Exp: 2028-07-11→ Common Stock (12,399 underlying)
Footnotes (5)
- [F1]On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. ("Merger Sub") and ArTara Subsidiary, Inc. ("ArTara Sub"). On January 9, 2020 (the "Effective Time"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer.
- [F2]Seven hundred seventy-four (774) of the Option Shares shall vest as of October 1, 2018, and the remaining Option Shares shall vest in forty five (45) approximately equal increments of two hundred fifty eight (258) whole Option Shares beginning on the first day of the fourth calendar month following the date of the grant (being November 1, 2018) and then on the first day of each of the next forty four (44) months thereafter (each a "Vesting Date"), if the Reporting Person has remained continuously engaged by the Issuer or any Affiliate through such Vesting Date; provided that, on the last such Vesting Date (being July 1, 2022), all of the Option Shares which had not vested by then will vest and become exercisable, and that the vesting of all then unvested Option Shares shall be accelerated upon a Change of Control.
- [F3]Received in the Merger in exchange for a stock option to acquire 65,000 shares of ArTara Sub common stock for $1.75 per share.
- [F4]The shares subject to this option shall vest in forty eight (48) approximately equal increments of one hundred thirty nine (139) whole Option Shares beginning on the first day of the first calendar month following December 4, 2018, and then on the first day of each of the next forty seven (47) months thereafter (each a "Vesting Date"), if Reporting Person has remained continuously engaged by the Issuer or any Affiliate through such Vesting Date; provided that, on the last such Vesting Date (being December 1, 2022), all of the Option Shares which had not vested by then (being not less than 139 Option Shares) will vest and become exercisable.
- [F5]Received in the Merger in exchange for a stock option to acquire 35,000 shares of ArTara Sub common stock for $1.75 per share.
Documents
Issuer
Protara Therapeutics, Inc.
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0001192128
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 1:30 PM ET
- Size
- 10.0 KB